Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.830
-0.070 (-1.43%)
Sep 28, 2026, 1:19 PM EDT - Market open
Champions Oncology Market Cap
Champions Oncology has a market cap or net worth of $67.23 million as of September 28, 2026. Its market cap has decreased by -22.64% in one year.
Market Cap
67.23M
Enterprise Value
73.84M
1-Year Change
-22.64%
Ranking
Category
Stock Price
$4.83
ChartMarket Cap Chart
Since August 21, 2015, Champions Oncology's market cap has increased from $45.90M to $67.23M, an increase of 46.46%. That is a compound annual growth rate of 3.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 67.23M | -29.97% |
| Dec 31, 2025 | 96.00M | -18.92% |
| Dec 31, 2024 | 118.40M | 54.97% |
| Dec 29, 2023 | 76.40M | 25.04% |
| Dec 30, 2022 | 61.10M | -45.93% |
| Dec 31, 2021 | 113.00M | -21.69% |
| Dec 31, 2020 | 144.30M | 49.07% |
| Dec 31, 2019 | 96.80M | 8.04% |
| Dec 31, 2018 | 89.60M | 110.33% |
| Dec 29, 2017 | 42.60M | 53.79% |
| Dec 30, 2016 | 27.70M | -10.93% |
| Dec 31, 2015 | 31.10M | -32.24% |
| Aug 21, 2015 | 45.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spero Therapeutics | 71.63M |
| Cingulate | 70.24M |
| Kalaris Therapeutics | 69.51M |
| Connect Biopharma Holdings | 68.01M |
| Pliant Therapeutics | 66.88M |
| Gossamer Bio | 66.85M |
| XBiotech | 66.16M |
| Alps Group | 65.89M |